Common-Size Income Statement
Paying user area
Try for free
DexCom Inc. pages available for free this week:
- Statement of Comprehensive Income
- Analysis of Profitability Ratios
- DuPont Analysis: Disaggregation of ROE, ROA, and Net Profit Margin
- Enterprise Value to EBITDA (EV/EBITDA)
- Enterprise Value to FCFF (EV/FCFF)
- Price to FCFE (P/FCFE)
- Operating Profit Margin since 2005
- Debt to Equity since 2005
- Price to Book Value (P/BV) since 2005
- Analysis of Debt
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to DexCom Inc. for $22.49.
This is a one-time payment. There is no automatic renewal.
We accept:
DexCom Inc., common-size consolidated income statement
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).
| Income statement item | Description | The company |
|---|---|---|
| Operating income (loss) | The net result for the period of deducting operating expenses from operating revenues. | DexCom Inc. operating income (loss) as a percentage of revenue decreased from 2020 to 2021 but then increased from 2021 to 2022 not reaching 2020 level. |
| Income (loss) before income taxes | Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. | DexCom Inc. income (loss) before income taxes as a percentage of revenue decreased from 2020 to 2021 but then increased from 2021 to 2022 exceeding 2020 level. |
| Net income (loss) | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. | DexCom Inc. net income (loss) as a percentage of revenue decreased from 2020 to 2021 but then slightly increased from 2021 to 2022. |